Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.86 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.86 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.66 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.66 |
| ▸ | MAPT | P10636 | 1/20 | 0.66 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.62 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9226059 | 1.00 | MEN1 (0.86) | MEN1KMT2AALOX5LTB4R2MAPT | |
| SCHEMBL9224629 | 1.00 | MEN1 (0.86) | MEN1KMT2AALOX5LTB4R2MAPT | |
| SCHEMBL9226055 | 1.00 | MEN1 (0.86) | MEN1KMT2AALOX5LTB4R2MAPT | |
| SCHEMBL9224625 | 1.00 | MEN1 (0.86) | MEN1KMT2AALOX5LTB4R2MAPT | |
| SCHEMBL31704060 | 1.00 | MEN1 (0.86) | MEN1KMT2AALOX5LTB4R2MAPT | |
| SCHEMBL10699234 | 0.99 | MEN1 (0.84) | MEN1KMT2AALOX5LTB4R2MAPT | |
| SCHEMBL30555723 | 0.99 | MEN1 (0.84) | MEN1KMT2AALOX5LTB4R2MAPT | |
| SCHEMBL29926784 | 0.99 | MEN1 (0.84) | MEN1KMT2AALOX5LTB4R2MAPT | |
| SCHEMBL2109521 | 0.95 | MEN1 (0.77) | MEN1KMT2AALOX5MAPT | |
| SCHEMBL1394974 | 0.95 | MEN1 (0.77) | MEN1KMT2AALOX5MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9670126-B2 | Methods of making 15-hydroxy fatty acid derivatives | DIGNITY SCIENCES LIMITED (IE) | 2017-06-06 | — | — | US | disclosed |
| US-9670126-B2 | Methods of making 15-hydroxy fatty acid derivatives | DIGNITY SCIENCES LIMITED (IE) | 2017-06-06 | — | — | US | disclosed |
| US-20150119593-A1 | METHODS OF MAKING 15-HYDROXY FATTY ACID DERIVATIVES | AFIMMUNE LIMITED (IE) | 2015-04-30 | — | — | US | disclosed |
| US-20150119593-A1 | METHODS OF MAKING 15-HYDROXY FATTY ACID DERIVATIVES | AFIMMUNE LIMITED (IE) | 2015-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150119593-A1 | METHODS OF MAKING 15-HYDROXY FATTY ACID DERIVATIVES | ALOX15, ALOX5, ALOX15B | MEN1 4741/4885KMT2A 2775/4885ALOX5 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.